Full Description
This concise, yet authoritative, clinical reference guide fulfils the needs of diverse clinicians, pharmacists and allied health professionals prescribing for Parkinson's disease and movement disorders in contemporary clinical practice. With chapters on newly approved drugs and their effects on motor and non-motor symptoms, information is also given on their use in particular populations including the elderly and patients with cognitive impairment. Each chapter includes pharmacological/biochemical rationale for drug use, a general guide to therapeutic use, pharmacokinetics, interaction profile, adverse effects, dosing and use, special population considerations, costs and value for money considerations, clinical vignette, a summary overview, and suggested reading. Ordered alphabetically and perfect for quick reference use, the guide is practical and essential for all prescribers with responsibility for patients with Parkinson's disease, including neurologists, geriatricians, internists, neurosurgeons, psychiatrists, family physicians, pharmacists as well as allied health professionals and resident, fellow, and student trainees in all related medical fields.
Contents
Foreword from Professor Chaudhuri; Introduction; Amantadine; Amitriptyline; Apomorphine Infusion; Apomorphine Injection; Apomorphine Sublingual; Botulinum; Citalopram; Clonazepam; Clozapine; Desimpramine; Domperidone; Donepezil; Droxidopa; Entacapone; Fludrocortisone; Glycopyrrolate; Istradefylline; Levodopa benserazide; Levodopa carbidopa; Levodopa carbidopa entacapone intestinal gel; Levodopa carbidopa intestinal gel; Levodopa inhaled; Lubipristone; Macrogol; Melatonin; Memantine; Midodrine; Mirabegron; Mirtazepine; Modafanil; Naltrexone; Nortriptyline; Opicapone; Oxybutynin; Piribedil; Pramipexole; Pimavenserin; Quetiapine; Rasagiline; Rivastigmine; Ropinirole; Rotigotine; Safinamide; Selegiline; Sildenafil; Solifenacin; Tolcapone; Tolterodine; Trihexyphenidyl; Venlafaxine; Zonisamide; Abbreviations.
